Rchr
J-GLOBAL ID:201701005117405993   Update date: Apr. 15, 2024

Doi Yohei

ドイ ヨウヘイ | Doi Yohei
Affiliation and department:
Job title: 教授
Other affiliations (1):
  • University of Pittsburgh School of Medicine
Research field  (2): Bacteriology ,  Infectious disease
Research keywords  (3): infectious diseases ,  clinical microbiology ,  bacteriology
Research theme for competitive and other funds  (7):
  • 2023 - 2026 非結核性抗酸菌が抗結核薬に耐性を示すメカニズムの解明と新規治療法開発への応用
  • 2022 - 2025 Developing randomized controlled trials for AMR infections
  • 2014 - 2025 COLISTIN RESISTANCE IN EXTENSIVELY DRUG-RESISTANT GRAM-NEGATIVE PATHOGENS
  • 2020 - 2022 MECHANISMS OF CEFIDEROCOL RESISTANCE
  • 2018 - 2021 STUDY NETWORK OF ACINETOBACTER AS A CARBAPENEM-RESISTANT PATHOGEN (SNAP)
Show all
Papers (384):
  • Brian Hayama, Sohei Harada, Masahiro Suzuki, Yohei Doi, Yusuke Nomura, Kotaro Aoki, Kazumi Takehana, Tomomi Akatsuchi, Taisuke Enokida, Koichi Takeda, et al. Outbreak of Streptococcus pyogenes emm89 ST646 in a head and neck surgical oncology ward. Microbiology spectrum. 2024. e0426023
  • Masataka Nakagawa, Yumiko Fujishiro, Yohei Doi, Junichi Yamakami, Hitoshi Honda. Differences in the incidence of nosocomial-onset COVID-19 among hospitalized patients with exposure to SARS-CoV-2. Infection Control & Hospital Epidemiology. 2024
  • Alina Iovleva, Christi L McElheny, Erin L Fowler, Eric Cober, Erica S Herc, Cesar A Arias, Carol Hill, Keri Baum, Vance G Fowler Jr, Henry F Chambers, et al. In vitro activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant Acinetobacter baumannii collected in U.S. hospitals. Antimicrobial agents and chemotherapy. 2024. 68. 3. e0125823
  • Masanao Sasaki, Hiroyuki Sato, Yukari Uemura, Ayako Mikami, Nao Ichihara, Shigeki Fujitani, Masashi Kondo, Yohei Doi, Eriko Morino, Daisuke Tokita, et al. How Much More Efficient Are Adaptive Platform Trials Than Multiple Stand-Alone Trials? A Comprehensive Simulation Study for Streamlining Drug Development During a Pandemic. Clinical pharmacology and therapeutics. 2024
  • Anna Clara M Galdino, Mylene Vaillancourt, Diana Celedonio, Kara Huse, Yohei Doi, Janet S Lee, Peter Jorth. Siderophores promote cooperative interspecies and intraspecies cross-protection against antibiotics in vitro. Nature microbiology. 2024. 9. 3. 631-646
more...
MISC (67):
  • 入山智沙子, 村田貴之, 河合昴治, 岡本晃直, 後藤尚絵, 山本秀行, 加藤駿晴, 藤垣英嗣, 飯田俊, 鈴木忠樹, et al. 濾胞性リンパ腫維持療法中に発症し,時間的空間的に付加的変異を獲得したBA.1.1COVID-19の一剖検例. 日本リンパ網内系学会会誌. 2023. 63
  • 早川 佳代子, 松村 康史, 櫻井 亜樹, 谷崎 隆太郎, 篠原 浩, 橋本 武博, 加藤 英明, 的野 多加志, 馳 亮太, 馬渡 桃子, et al. ESBL産生大腸菌による侵襲性尿路感染症におけるセファマイシン系抗菌薬の有効性評価. 感染症学雑誌. 2022. 96. 臨増. 121-121
  • 早川佳代子, 松村康史, 櫻井亜樹, 谷崎隆太郎, 篠原浩, 橋本武博, 加藤英明, 的野多加志, 馳亮太, 馬渡桃子, et al. ESBL産生大腸菌による侵襲性尿路感染症におけるセファマイシン系抗菌薬の有効性評価. 感染症学雑誌(Web). 2022. 96
  • 齋藤翔, 櫻井亜樹, 和泉翔喜, 馳亮太, 橋本武博, 伊東直哉, 松村康史, 加藤英明, 的野多加志, 鈴木哲也, et al. カルバペネム耐性および感受性緑膿菌感染症の予後比較:Multi-Drug Resistant organisms clinical research network(MDRnet). 日本感染症学会東日本地方会学術集会・日本化学療法学会東日本支部総会合同学会プログラム・抄録集. 2022. 71st-69th
  • 藤垣英嗣, 竹村正男, 大澤道子, 藤田孝, 水谷謙明, 酒井好美, 土井洋平, 秋山秀彦, 畑忠善, 斉藤邦明, et al. Evaluation of VITROS Anti-SARS CoV-2 IgG Assay with VITROS 5600 II Integrated System. 医学と薬学. 2021. 78. 3
more...
Books (2):
  • Ertapenem, Imipenem, Meropenem, Doripenem, and Aztreonam, In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 9th edition, Mandell GL ed.
    Elsevier 2019
  • Penicillins and beta-Lactamase Inhibitors, In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 9th edition, Mandell GL ed.
    Elsevier 2019
Education (2):
  • 2001 - 2004 Nagoya University Graduate School of Medicine
  • 1992 - 1998 Nagoya University School of Medicine
Professional career (1):
  • 分子病態内科学 (名古屋大学)
Work history (9):
  • 2021/02 - 現在 University of Pittsburgh School of Medicine Division of Infectious Diseases Professor of Medicine
  • 2018/04 - 現在 Fujita Health University School of Medicine Department of Infectious Diseases Professor
  • 2017/04 - 現在 Fujita Health University School of Medicine Department of Microbiology Professor
  • 2016/02 - 2021/01 University of Pittsburgh School of Medicine Division of Infectious Diseases Associate Professor of Medicine
  • 2008/07 - 2016/01 University of Pittsburgh School of Medicine Division of Infectious Diseases Assistant Professor of Medicine
Show all
Committee career (4):
  • 2021/04 - 現在 Japan Agency for Medical Research and Development (AMED) Program Supervisor
  • 2018/10 - 現在 Infectious Diseases Society of America IDWeek Program Committee
  • 2013/12 - 現在 Antibacterial Resistance Leadership Group Gram-Negative Committee
  • 2019/06 - 2022/06 American Society for Microbiology ASM Microbe Program Committee
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page